ASHLEY CARPENTER: Open Payments
NPI 1720526692 · FESTUS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$178 in 8 payments from 7 companies in 2025. Trend: 2023 $200 · 2024 $115 · 2025 $178
Food & beverage: $178
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 2 | $42 |
| BETA BIONICS, INC. | 1 | $35 |
| ABBVIE INC. | 1 | $24 |
| Abbott Laboratories | 1 | $23 |
| Amgen Inc. | 1 | $21 |
| Genentech USA, Inc. | 1 | $16 |
| Novo Nordisk Inc | 1 | $16 |
Products named: Dexcom G6 Transmitter, iLet Bionic Pancreas, VRAYLAR, FREESTYLE LIBRE, EVENITY, Xolair, Ozempic.
Industry payments across MO — which companies pay providers there.
